|
SART3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.967800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.682800E-03 |
| Normal-vs-Stage2 |
7.512000E-02 |
| Normal-vs-Stage3 |
7.618500E-04 |
| Normal-vs-Stage4 |
9.189100E-04 |
| Stage1-vs-Stage2 |
9.158000E-01 |
| Stage1-vs-Stage3 |
2.285400E-01 |
| Stage1-vs-Stage4 |
2.801000E-01 |
| Stage2-vs-Stage3 |
3.623600E-01 |
| Stage2-vs-Stage4 |
4.450200E-01 |
| Stage3-vs-Stage4 |
9.260000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.542050E-03 |
| Normal-vs-AfricanAmerican |
5.816400E-01 |
| Normal-vs-Asian |
4.589700E-02 |
| Caucasian-vs-AfricanAmerican |
1.682800E-01 |
| Caucasian-vs-Asian |
7.068600E-01 |
| AfricanAmerican-vs-Asian |
3.048800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.195300E-04 |
| Normal-vs-Female |
2.376300E-03 |
| Male-vs-Female |
2.349800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.563200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.012040E-02 |
| Normal-vs-Age(61-80Yrs) |
2.190400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.214170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.805600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.961190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.237800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.211190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.437400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.739800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.986190E-02 |
| Classical-VS-Follicular |
1.386220E-02 |
| Classical-VS-Other |
8.969600E-02 |
| Classical-VS-Normal |
5.217900E-02 |
| Tall-VS-Follicular |
8.578600E-01 |
| Tall-VS-Other |
5.974800E-01 |
| Tall-VS-Normal |
4.392200E-04 |
| Follicular-VS-Other |
6.645600E-01 |
| Follicular-VS-Normal |
5.615800E-04 |
| Other-VS-Normal |
1.303830E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.779300E-04 |
| Normal-vs-N1 |
1.783900E-04 |
| N0-vs-N1 |
1.893390E-01 |
|
|
